title: Akt inhibitors: mechanism of action and implications for anticancer therapeutics.
abstract: Akt, better known as protein kinase B (PKB), is a serine/threonine-specific protein kinase which acts as mediator via PI3K/Akt pathway in many biological processes like glucose metabolism, apoptosis, cell differentiation and transcription. Akt1 gene amplification has been implicated in gastric carcinoma while Akt2 amplification has been linked with ovarian, pancreas, breast and stomach tumors. The use of Akt inhibitors as monotherapy or in combination with other anticancer drugs could be useful for combating drug resistance and improving response. Thus, comprehensive understanding of Akt and its linked signaling pathways (PI3K, PKB, mTOR etc.) is necessary to lead to newer drug development and use.
authors: Jaikrit
authors: J
authors: Bhutani
authors: Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. asfandyarsheikh@gmail.com.
authors: Asfandyar
authors: A
authors: Sheikh
authors: Asfandyar Khan
authors: AK
authors: Niazi